WOSCOPS

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia - The New England Journal of Medicine - 1995

Brief Summary:

Among men with hyperlipidemia, pravastatin reduced the composite endpoint of nonfatal MI or death from CAD at 5 years.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/7566020

Comments